îæ€çŽ¢
îæ€çŽ¢
î
Veracyte Inc
VCYTîãŠã©ãããªã¹ãã«è¿œå
41.250USD
-1.350-3.17%
çµå€Â 08-14 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
3.32Bæ䟡ç·é¡
37.00çŽè¿12ã¶æPER
äºæž¬å€
é貚: USD æŽæ°æå»: 2026-08-14Veracyte Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.46ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž126äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯48.00ã§ãæé«ã¯57.00ãæäœã¯43.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
13
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
57.333
ç®æšæ ªäŸ¡
+28.32%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
497
åèš
6
äžå€®å€
7
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Veracyte Inc
VCYT
13
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Veracyte Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îVeracyte Inc ã®äºæ³åç㯠147.55M ã§ãã
Veracyte Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãVeracyte Inc ã®ç®æšæ ªäŸ¡ã USD 48.00 ãšäºæ³ããæé«äºæ³ã¯ USD 57.00ãæäœäºæ³ã¯ USD 43.00 ãšäºæ³ããŠããŸãã
Veracyte IncVCYT ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD 0.32 ã§ããããVeracyte IncVCYT ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.36 ã§ããã次ã®ååæã® EPS 㯠USD 0.25 ãšäºæ³ãããŸãã
Veracyte Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î13 ã¢ããªã¹ãã«ãã Veracyte Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Veracyte Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã